ArticlePlatelets2013
Effects of oxidative stress on amyloid precursor protein processing in rat and human platelets.
Article in Platelets, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 23 citations in OpenAlex.
- Perspectives on Alzheimer's Disease Treatment Based on Counteracting Oxidative Stress.Biomolecules · 2025Review
- Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer's Disease.Aging and disease · 2020Review
- Peripheral and central administration of T3 improved the histological changes, memory and the dentate gyrus electrophysiological activity in an animal model of Alzheimer's disease.Metabolic brain disease · 2017Article
- Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice.Trends in neurosciences · 2016Review
- Effect of Gallic Acid on Dementia Type of Alzheimer Disease in Rats: Electrophysiological and Histological Studies.Basic and clinical neuroscience · 2016Article
- Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Biogerontology · 2015Article
- Effects of ethanol on aggregation, serotonin release, and amyloid precursor protein processing in rat and human platelets.Platelets · 2014Article
- Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease.Current neurovascular research · 2013Article
- Antidepressants and anti-inflammatory drugs differentially reduce the release of NGF and BDNF from rat platelets.Pharmacopsychiatry · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative illness affecting the elderly and is characterized by beta-amyloid (Aβ) deposition in the brain (plaques) and in microvessels (Aβ-angiopathy). The reasons for Aβ deposition are not clear, but an impaired clearance of Aβ at the blood-brain barrier may be implicated and oxidative stress possibly plays a major role in this process. Platelets are of particular interest, because they contain high levels of the amyloid precursor protein (APP) and in AD an abnormal expression of platelets APP fragments was found. The aim of the present study was to investigate (1) if oxidative stress induced by hydrogen peroxide (H(2)O(2)) affects APP expression in rat and human platelets and (2) to compare the APP changes with platelets of AD patients. In rat platelets, all three fragments of APP (130-110-106 kilo Dalton, kDa) were found. H(2)O(2) (10 mM, 20 minutes) significantly reduced all three fragments in rat platelets, did not affect CD62P-staining and slightly increased the size of actin as seen in the Western blot. The effect was not seen at 1 mM H(2)O(2) and was counteracted by glutathione. Immunohistochemistry for CD62P, CD61, APP and Annexin-V was used to verify the changes at the cellular level. In platelets of young volunteers (age = 33 ± 4 years), 10 mM H(2)O(2) markedly reduced the smaller APP 110 and 106 kDa fragments after 20 minutes. Our data show that platelets of AD patients (age = 80 ± 1 years) had a significant reduced 130 kDa fragment compared to controls (age = 70 ± 2 years). In summary, oxidative stress may account for a dysfunctional processing of APP in rat and human control platelets and possibly in AD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.